x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    Liquid Biopsy Reveals ERBB3-PIK3CA Activation and MYC Amplification Driving Resistance in Metastatic Cervical Cancer

    More Author(s)

    50 y/ female diagnosed with poorly differentiated squamous cell carcinoma of cervix
    • Initial Treatment: Initially treated with chemotherapy, brachytherapy, radiotherapy. Later, disease recurrence with multiple 
    nodal mets -> Pac+Carbo+Bev. Further progression, treated with Gem+Nab-Pac. 
    • Further evaluation: Presently on Pem+Carbo+ZA. Comprehensive molecular profiling via OncoIndx Liquid Biopsy to understand 
    molecular cause for recurrence and aggressiveness and identify possible treatment resistance and directives

    Related Articles

    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.